1. Home
  2. SLNO vs AMBA Comparison

SLNO vs AMBA Comparison

Compare SLNO & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • AMBA
  • Stock Information
  • Founded
  • SLNO 1999
  • AMBA 2004
  • Country
  • SLNO United States
  • AMBA United States
  • Employees
  • SLNO N/A
  • AMBA N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AMBA Semiconductors
  • Sector
  • SLNO Health Care
  • AMBA Technology
  • Exchange
  • SLNO Nasdaq
  • AMBA Nasdaq
  • Market Cap
  • SLNO 3.8B
  • AMBA 3.3B
  • IPO Year
  • SLNO 2014
  • AMBA N/A
  • Fundamental
  • Price
  • SLNO $79.98
  • AMBA $51.68
  • Analyst Decision
  • SLNO Strong Buy
  • AMBA Buy
  • Analyst Count
  • SLNO 9
  • AMBA 11
  • Target Price
  • SLNO $103.33
  • AMBA $83.18
  • AVG Volume (30 Days)
  • SLNO 662.7K
  • AMBA 1.1M
  • Earning Date
  • SLNO 08-06-2025
  • AMBA 05-29-2025
  • Dividend Yield
  • SLNO N/A
  • AMBA N/A
  • EPS Growth
  • SLNO N/A
  • AMBA N/A
  • EPS
  • SLNO N/A
  • AMBA N/A
  • Revenue
  • SLNO N/A
  • AMBA $316,264,000.00
  • Revenue This Year
  • SLNO N/A
  • AMBA $25.24
  • Revenue Next Year
  • SLNO N/A
  • AMBA $10.01
  • P/E Ratio
  • SLNO N/A
  • AMBA N/A
  • Revenue Growth
  • SLNO N/A
  • AMBA 44.54
  • 52 Week Low
  • SLNO $36.93
  • AMBA $38.86
  • 52 Week High
  • SLNO $81.54
  • AMBA $85.15
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 60.77
  • AMBA 41.67
  • Support Level
  • SLNO $76.14
  • AMBA $50.59
  • Resistance Level
  • SLNO $81.54
  • AMBA $52.82
  • Average True Range (ATR)
  • SLNO 2.49
  • AMBA 1.88
  • MACD
  • SLNO 0.00
  • AMBA -0.56
  • Stochastic Oscillator
  • SLNO 81.81
  • AMBA 20.80

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

Share on Social Networks: